Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epithelial cells lining mucosal surfaces impose multiple barriers to viral infection. At the ocular surface, the carbohydrate-binding protein
galectin-3
maintains barrier function by cross-linking transmembrane mucins on the apical glycocalyx. Despite these defense mechanisms, many viruses have evolved to exploit fundamental cellular processes on host cells. Here, we use affinity assays to show that herpes simplex virus type 1 (HSV-1), but not HSV-2, binds human
galectin-3
. Knockdown of
galectin-3
in human corneal keratinocytes by small interfering RNA significantly impaired HSV-1 infection, but not expression of
nectin-1
, indicating that
galectin-3
is a herpesvirus entry mediator. Interestingly, exposure of epithelial cell cultures to transmembrane mucin isolates decreased viral infectivity. Moreover, HSV-1 failed to elute the biological counterreceptor MUC16 from
galectin-3
affinity columns, suggesting that association of transmembrane mucins to
galectin-3
provides protection against viral infection. Together, these results indicate that HSV-1 exploits
galectin-3
to enhance virus attachment to host cells and support a protective role for transmembrane mucins under physiological conditions by masking viral entry mediators on the epithelial glycocalyx.
...
PMID:Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. 2348 60